A mouse model of retinal inflammation induced by the intravitreal injection of amyloid β
Lei Chunyan,Wang Jiaming,Zheng Shijie,Tao Lifei,Lei Bo.
Department of Ophthalmology, the First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, Chongqing 400016, China
Objective To establish a mouse model of retinal inflammation induced by the intravitreal injection of amyloid β (Aβ), a major component in drusen. Methods This was an experimental study in C57BL/6J mice to determine the optimal concentration of Aβ1-40, the mRNA expressions of inflammatory cytokines interleukin-6 (IL-6), the tumor necrosis factor-α (TNF-α) and nucleotide-binding oligomerization domain leucine-rich repeats containing pyrin domain 3 (NLRP3) inflammasome were examined at 24 hours after the intravitreal injection of 2 µl of PBS or different concentrations (0.5, 1.0, 1.5, 2.0 µg/µl) of Aβ1-40. After determination of the concentration, mice were injected with optimal concentrations of Aβ1-40 (n=12) or Aβ40-1 (n=12) and the eyeballs were enucleated at days 1, 4 and 14 postinjection. The expression of inflammatory cytokines and the activation of NLRP3 inflammasome in the neuroretina and the RPE/choroid complex were analyzed by real-time PCR. The severity of retinal damage was evaluated with HE staining at day 4 postinjection (n=3 for each group), and retinal functions were evaluated by ERG at days 4 and 14 (n=12 in PBS group, n=8 in Aβ40-1 group and Aβ1-40 group). Differences between groups were analyzed using ANOVA followed by a post hoc Bonferroni correction. Results The optimal concentration of Aβ1-40 that could induce retinal inflammation was 1.0 µg/µl. Compared with Aβ40-1, Aβ1-40 significantly upregulated the expressions of IL-6, TNF-α and NLRP3 inflammasome genes in the neuroretina and the RPE/choroid complex at days 1 and 4 postinjection. The differences in inflammatory cytokine gene expression between these groups were not significant at day 14, except for the TNF-α in the neuroretina group. No structural disorganization or inflammatory cell infiltration was observed in the retina in each group under light microscopy at day 4. At days 4 and 14 after intravitreal injection, the amplitudes of ERG a- and b-waves significantly decreased in the Aβ1-40 injected mice compared to the untreated and the Aβ40-1 injected mice. No significant differences were observed between the untreated and Aβ40-1 groups at day 14, except for the amplitudes of the dark-adapted ERG b-wave recorded with light intensities of 1.0 and 10.0 cd·s/m2. Conclusion Our data show that Aβ1-40 induces a transient proinflammatory response in the neuroretina and the RPE/choroid complex, and causes retinal functional impairment. These responses mimic those observed in the early stages of age-related macular degeneration (AMD) patients. We find inflammasome is activated in this process. This novel model is useful for investigating the pathogeneses of early AMD.
雷春燕,汪家名,郑仕洁,陶丽妃,雷博. 玻璃体腔注射β淀粉样蛋白制作视网膜炎症模型[J]. 中华眼视光学与视觉科学杂志, 2016, 18(1): 8-13.
Lei Chunyan,Wang Jiaming,Zheng Shijie,Tao Lifei,Lei Bo. . A mouse model of retinal inflammation induced by the intravitreal injection of amyloid β. Chinese Journal of Optometry Ophthalmology and Visual science, 2016, 18(1): 8-13. DOI: DOI:10.3760/cma.j.issn.1674-845X.2016.01.003
Klein R, Chou CF, Klein BE, et al. Prevalence of age-related macular degeneration in the US population[J]. Arch Ophthalmol, 2011,129(1):75-80. DOI:10.1001/archophthalmol.2010.318.
Liu RT, Gao J, Cao S, et al. Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration [J]. Invest Ophthalmol Vis Sci,2013,54(3):2225-2237. DOI:10. 1167/iovs.12-10849.
[4]
Liu C, Cao L, Yang S, et al. Subretinal injection of amyloid-beta peptide accelerates RPE cell senescence and retinal degeneration[J]. Int J Mol Med,2015,35(1):169-176. DOI: 10.3892/ijmm.2014.1993.
[5]
Nakazawa T, Kayama M, Ryu M, et al. Tumor necrosis factor-alpha mediates photoreceptor death in a rodent model of retinal detachment[J]. Invest Ophthalmol Vis Sci,2011,52(3):1384-1391. DOI:10.1167/iovs.10-6509.
[6]
Howlett DR, Bate ST, Collier S, et al. Characterisation of amyloid-induced inflammatory responses in the rat retina[J]. Exp Brain Res,2011,214(2):185-197. DOI:10.1007/s00221-011-2819-4.
Liu RT, Wang A, To E, et al. Vinpocetine inhibits amyloid-beta induced activation of NF-kappaB, NLRP3 inflammasome and cytokine production in retinal pigment epithelial cells[J]. Exp Eye Res,2014,127:49-58. DOI:10.1016/j.exer.2014.07.003.
[9]
Sendrowski K, Sobaniec W, Stasiak-Barmuta A, et al. Study of the protective effects of nootropic agents against neuronal damage induced by amyloid-beta (fragment 25-35) in cultured hippocampal neurons[J]. Pharmacol Rep,2015,67(2):326-331. DOI: 10.1016/j.pharep.2014.09.013.
[10]
Viel JJ, Mcmanus DQ, Smith SS, et al. Age- and concentration-dependent neuroprotection and toxicity by TNF in cortical neurons from beta-amyloid[J]. J Neurosci Res,2001,64(5):454-465.
[11]
Seddon JM, George S, Rosner B, et al. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers[J]. Arch Ophthalmol,2005,123(6):774-782. DOI:10.1001/archopht.123.6.774.
[12]
Tarallo V, Hirano Y, Gelfand BD, et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88[J]. Cell,2012,149(4):847-859. DOI:10. 1016/j.cell.2012.03.036.
Hoh Kam J, Lenassi E, Jeffery G. Viewing ageing eyes: diverse sites of amyloid Beta accumulation in the ageing mouse retina and the up-regulation of macrophages[J]. PLoS One,2010,5(10):e13127. DOI:10.1371/journal.pone.0013127.
[15]
Yehoshua Z, Rosenfeld PJ, Albini TA. Current Clinical Trials in Dry AMD and the Definition of Appropriate Clinical Outcome Measures[J]. Semin Ophthalmol,2011,26(3):167-180. DOI:10.3109/ 08820538.2011.577132.